Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Amortization of Deferred Charges (2016 - 2026)

Lantheus Holdings (LNTH) posted quarterly Amortization of Deferred Charges of $1.1 million for Q1 2026, little changed year-over-year from $1.1 million in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.

Lantheus Holdings (LNTH) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Amortization of Deferred Charges for 11 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.5 million (up 2.74% YoY), while the FY2025 annual figure was $4.5 million, up 3.75% from the prior year.
  • Amortization of Deferred Charges was little changed at $1.1 million in Q1 2026 per LNTH's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.1 million in Q1 2025 and bottomed at $245000.0 in Q2 2022.
  • Historically, Amortization of Deferred Charges has averaged $906882.4 across 5 years, with a median of $1.1 million in 2023.
  • Annual changes were most pronounced in 2022 — Amortization of Deferred Charges jumped 503.28% — and 2024, when it retreated 0.83%.
  • Lantheus Holdings' Amortization of Deferred Charges stood at $512000.0 in 2022, then soared by 109.57% to $1.1 million in 2023, then grew by 0.56% to $1.1 million in 2024, then grew by 3.24% to $1.1 million in 2025, then gained by 0.09% to $1.1 million in 2026.
  • Business Quant data shows LNTH's Amortization of Deferred Charges at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.12 Mn
Jun 30, 2026 1.12 Mn
Mar 31, 2026 1.12 Mn
Mar 31, 2026 1.12 Mn
Dec 31, 2025 1.11 Mn
Dec 31, 2025 1.11 Mn
Sep 30, 2025 1.11 Mn
Sep 30, 2025 1.11 Mn
Jun 30, 2025 1.12 Mn
Jun 30, 2025 1.12 Mn
Mar 31, 2025 1.12 Mn
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.08 Mn
Dec 31, 2024 1.08 Mn
Sep 30, 2024 1.07 Mn
Sep 30, 2024 1.07 Mn
Jun 30, 2024 1.07 Mn
Jun 30, 2024 1.07 Mn
Mar 31, 2024 1.07 Mn
Mar 31, 2024 1.07 Mn